|
WO2017193046A1
(en)
|
2016-05-06 |
2017-11-09 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
AU2018219887B2
(en)
|
2017-02-08 |
2024-08-15 |
Dragonfly Therapeutics, LLC |
Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer
|
|
CN110944661A
(zh)
|
2017-02-20 |
2020-03-31 |
蜻蜓疗法股份有限公司 |
结合her2、nkg2d和cd16的蛋白质
|
|
US20200306375A1
(en)
*
|
2017-02-22 |
2020-10-01 |
Aleta Biotherapeutics Inc. |
Compositions and methods for tumor transduction
|
|
AU2018225164A1
(en)
*
|
2017-02-22 |
2019-09-19 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
SG11202004116QA
(en)
|
2017-11-08 |
2020-06-29 |
Biontech Us Inc |
T cell manufacturing compositions and methods
|
|
CN111315405A
(zh)
*
|
2017-11-09 |
2020-06-19 |
免疫医疗有限责任公司 |
双特异性融合多肽及其使用方法
|
|
CA3237846A1
(en)
|
2018-02-08 |
2019-08-15 |
Dragonfly Therapeutics, Inc. |
Antibody variable domains targeting the nkg2d receptor
|
|
BR112020015994A2
(pt)
|
2018-02-08 |
2020-12-15 |
Dragonfly Therapeutics, Inc. |
Terapia de combinação do câncer que envolve proteínas de ligação multiespecíficas que ativam células natural killer
|
|
WO2019164930A1
(en)
|
2018-02-20 |
2019-08-29 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
|
|
TWI822726B
(zh)
|
2018-02-26 |
2023-11-21 |
德商梅迪基因免疫治療公司 |
Ｎｙｅｓｏ ｔ細胞受體
|
|
KR20210018275A
(ko)
*
|
2018-05-07 |
2021-02-17 |
드래곤플라이 쎄라퓨틱스, 인크. |
Nkg2d, cd16 및 종양-연관 항원에 결합하는 단백질
|
|
CN110507824A
(zh)
*
|
2018-05-21 |
2019-11-29 |
荣昌生物制药（烟台）有限公司 |
一种抗间皮素抗体及其抗体药物缀合物
|
|
KR102870868B1
(ko)
|
2018-06-01 |
2025-10-15 |
노파르티스 아게 |
Bcma에 대한 결합 분자 및 이의 용도
|
|
EP3833392A4
(en)
|
2018-08-08 |
2022-05-18 |
Dragonfly Therapeutics, Inc. |
MULTISPECIFIC BINDING PROTEINS FOR BINDING CD33, NKG2D AND CD16 AND METHODS OF USE
|
|
KR102835308B1
(ko)
|
2018-08-08 |
2025-07-21 |
드래곤플라이 쎄라퓨틱스, 인크. |
Nkg2d, cd16 및 종양 관련 항원에 결합하는 단백질
|
|
EA202091888A1
(ru)
|
2018-08-08 |
2020-10-23 |
Драгонфлай Терапьютикс, Инк. |
Вариабельные домены антител, нацеленные на рецептор nkg2d
|
|
WO2020084608A1
(en)
*
|
2018-10-22 |
2020-04-30 |
Explore Bio 1 Ltd |
Precursor bispecific antibody constructs and methods of use thereof
|
|
SG11202104180WA
(en)
*
|
2018-10-30 |
2021-05-28 |
Peter Maccallum Cancer Inst |
Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof
|
|
AU2019372673A1
(en)
*
|
2018-11-01 |
2021-05-27 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for T cell engineering
|
|
US20220089719A1
(en)
*
|
2019-01-08 |
2022-03-24 |
Labyrx Immunologic Therapeutics (Usa) Limited |
Constructs targeting labyrinthin or a portion thereof and uses thereof
|
|
CN113646334B
(zh)
*
|
2019-02-20 |
2025-09-16 |
国家儿童医院研究所 |
癌症靶向的、病毒编码的、可调节的t细胞（catvert）或nk细胞（catvern）接头
|
|
CN118994397A
(zh)
*
|
2019-05-21 |
2024-11-22 |
诺华股份有限公司 |
针对bcma的三特异性结合分子及其用途
|
|
JP7489407B2
(ja)
|
2019-05-21 |
2024-05-23 |
ノバルティス アーゲー |
Ｃｄ１９結合分子及びその使用
|
|
RS66218B1
(sr)
|
2019-07-01 |
2024-12-31 |
Tonix Pharma Ltd |
Anti-cd154 antitela i njihove upotrebe
|
|
WO2021057906A1
(zh)
*
|
2019-09-25 |
2021-04-01 |
科济生物医药（上海）有限公司 |
表达il-15的免疫效应细胞
|
|
CN111235113A
(zh)
*
|
2020-01-21 |
2020-06-05 |
南京北恒生物科技有限公司 |
包含嵌合抗原受体的免疫细胞及其用途
|
|
JP7512394B2
(ja)
|
2020-05-06 |
2024-07-08 |
ドラゴンフライ セラピューティクス， インコーポレイテッド |
Ｎｋｇ２ｄ、ｃｄ１６及びｃｌｅｃ１２ａに結合するタンパク質
|
|
GB202008688D0
(en)
*
|
2020-06-09 |
2020-07-22 |
Cancer Research Tech Ltd |
Chimeric antigen receptor cell
|
|
US20240000937A1
(en)
*
|
2020-09-22 |
2024-01-04 |
World Biotech Regenerative Medical Group Limited |
Methods and compositions of car-expressing natural killer cells with bispecific antigen-binding molecules as cancer therapeutic agents
|
|
WO2022150452A1
(en)
|
2021-01-06 |
2022-07-14 |
Seth Lederman |
Methods of inducing immune tolerance with modified anti-cd154 antibodies
|
|
EP4301774A4
(en)
|
2021-03-03 |
2025-08-13 |
Dragonfly Therapeutics Inc |
METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN
|
|
IL309208A
(en)
|
2021-06-11 |
2024-02-01 |
Sage Therapeutics Inc |
Neuroactive steroid for the treatment of alzheimer's disease
|
|
CN117897404A
(zh)
*
|
2021-08-02 |
2024-04-16 |
信达生物制药(苏州)有限公司 |
抗CD79b×CD3双特异性抗体及其用途
|
|
US20250002574A1
(en)
*
|
2021-08-12 |
2025-01-02 |
Sunshine Lake Pharma Co., Ltd. |
Il-11 humanized antibody and application thereof
|
|
EP4405379A4
(en)
*
|
2021-09-24 |
2025-08-20 |
Synergy Imt Inc |
COMPOSITION OF RECOMBINANT ANTIGEN-BINDING MOLECULES AND METHOD OF MANUFACTURE AND USE THEREOF
|
|
TW202340474A
(zh)
*
|
2022-01-11 |
2023-10-16 |
大陸商深圳市珈鈺生物科技有限公司 |
樹突細胞腫瘤疫苗和其用途
|
|
CN115368446B
(zh)
*
|
2022-07-19 |
2025-08-08 |
合肥天港免疫药物有限公司 |
双特异性抗体及其应用
|
|
JP2026502768A
(ja)
|
2022-10-25 |
2026-01-27 |
アブレクシス， エルエルシー |
抗ｃｄ３抗体
|
|
WO2024107731A2
(en)
|
2022-11-14 |
2024-05-23 |
Ablexis, Llc |
Anti-pd-l1 antibodies
|
|
CN121127253A
(zh)
*
|
2023-02-28 |
2025-12-12 |
朱诺治疗学股份有限公司 |
治疗系统性自身免疫性疾病的细胞疗法
|
|
TW202547884A
(zh)
*
|
2024-03-15 |
2025-12-16 |
美商艾爾維克醫療公司 |
Ｍｕｃ１６／ｎａｐｉ－２ｂ抗體及使用方法
|
|
CN117965633A
(zh)
*
|
2024-04-01 |
2024-05-03 |
北京双赢科创生物科技有限公司 |
一种IFNγ受体敲除的CAR-T细胞的制备方法与应用
|
|
WO2025248134A1
(en)
|
2024-05-31 |
2025-12-04 |
Tonix Pharma Limited |
Treatment methods comprising administration of modified cd154 antibodies
|